With the move to precision medicine, especially in oncology, the inclusion of diverse populations in research and development can be a matter of life and death. Thought of another way, with ethnic minorities and others considered underrepresented experiencing cancer at greater rates, these population segments generally participate far less in what can be life-saving oncology research. As COVID-19 has clearly demonstrated, from the clinic to research, the embrace of diversity characterizes a fundamental step in progressing the nation's healthcare outcomes. After all, the United States is more ethnically and racially diverse than most other developed nations. Now the Barbara Ann Karmanos Cancer Institute, already a pathbreaker when it comes to working for health equity, has launched the Diversity and Inclusion Committee to integrate best practices, inclusion, and cultural competence in an ongoing quest to deliver continuously better and more equitable medical care. Perhaps this Midwestern cancer center develops a model for inclusion that others can learn from.
A Major Provider Network
Based in Detroit, a heavily African American populated city, the Barbara Ann Karmanos Ca...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).